Avidity Biosciences to Participate in Upcoming Investor Conferences

LA JOLLA, Calif.: LA JOLLA, Calif., Aug. 31, 2021 /PRNewswire/ — Avidity Biosciences, Inc. (NASDAQ: RNA) a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that the Avidity management team will be participating at the following conferences: 2021 Wells Fargo Virtual Healthcare ConferenceSeptember 9th, 202111:20am ET – Fireside Chat
Click here to view original post

ADVERTISEMENT — Advertise With Biotech Networks